New drugs promise to change the therapeutic landscape of breast cancer. First results from a phase III clinical trial of the combination drug, T-DM1, show that it significantly improves the length of time before the disease worsens in women with advanced HER2 positive breast cancer whose cancer has recurred or progressed despite previous treatments, including trastuzumab and lapatinib. In a late-breaking presentation to the 2013 European Cancer Congress ...You have just read an article categorized health
titled Women With Advanced Breast Cancer may Benefit from Anti-Cancer Drug T-DM1.
Written by:
editor - Saturday, September 28, 2013
There are currently no comments for "Women With Advanced Breast Cancer may Benefit from Anti-Cancer Drug T-DM1"
Post a Comment